Cell MedX Corp
OTC:CMXC

Watchlist Manager
Cell MedX Corp Logo
Cell MedX Corp
OTC:CMXC
Watchlist
Price: 134.435 USD -1.74% Market Closed
Market Cap: 40B USD
Have any thoughts about
Cell MedX Corp?
Write Note

Cell MedX Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cell MedX Corp
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Cell MedX Corp
OTC:CMXC
Operating Income
-$268.4k
CAGR 3-Years
27%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.8B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%

See Also

What is Cell MedX Corp's Operating Income?
Operating Income
-268.4k USD

Based on the financial report for May 31, 2024, Cell MedX Corp's Operating Income amounts to -268.4k USD.

What is Cell MedX Corp's Operating Income growth rate?
Operating Income CAGR 5Y
17%

Over the last year, the Operating Income growth was 40%. The average annual Operating Income growth rates for Cell MedX Corp have been 27% over the past three years , 17% over the past five years .

Back to Top